ArticleScientific reports2022

Involvement of the HERV-derived cell-fusion inhibitor, suppressyn, in the fusion defects characteristic of the trisomy 21 placenta.

Jun Sugimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.